PT

Dados B3 › BPHA3 × RDOR3

BPHA3 × RDOR3

BPHA3

MASSA FALIDA DA BRASIL PHARMA SA
Saúde

15 restated figures

RDOR3

REDE D'OR SÃO LUIZ S.A.
Saúde

10 restated figures

Indicators

Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.

indicatorBPHA3RDOR3year
ROE-149.5%21.3%no year where both have it (2016 × 2025)
ROIC-348.5%!29.7%no year where both have it (2017 × 2025)
ROA966.4%!6.2%!2018
Gross margin98.3%!25.7%2018
EBIT margin-302.4%!20.9%2018
Net margin10,996.5%!10.8%2018
Net debt/EBITDA19.79x0.48xno year where both have it (2013 × 2025)
Current ratio0.06x!3.69x2018
Revenue growth (1y)-17.5%!10.2%no year where both have it (2018 × 2025)
Revenue growth (5y CAGR)-68.9%!31.8%no year where both have it (2018 × 2025)
Piotroski F-Score5/9!2/9!2018

Point-in-time multiples

Priced at the first session on or after the day each filing became public — never the period close.

indicatorBPHA3RDOR3year
P/E0.15x20.48x2018 × 2025
P/B—4.96x2018 × 2025
EV/EBITDA—8.68x2018 × 2025
FCF yield-55.2%-2.9%2018 × 2025

BPHA3 · RDOR3 · filter the whole market · methodology

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:21 UTC. If this does not match /saude, you are reading a cached copy.

Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.

Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:21 UTC. If this does not match /saude, you are reading a cached copy.